SLBT

SL Science Holding Ltd

1.60

Oct 01 • 3:59 PM ET -0.10 (-5.88%)

1.72

Aftermarket • 6:03 PM ET +0.12 (7.63%)

Healthcare Biotechnology Taiwan Small NASD

Peers: SRPT IMCR BCAX MRVI ANAB TYRA ZYME FTRE LKFT RXRX

Index	-
Market Cap	897.22M
Enterprise Value	-
Income	-
Sales	-
Book/sh	-
Cash/sh	-
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Jun 15, 2026

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	-
P/C	-
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	-
Current Ratio	-
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-
Sales Q/Q	-
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	59.54%
Insider Trans	1.38%
Inst Own	0.11%
Inst Trans	114.24%
ROA	-
ROE	-
ROIC	-
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-20.10%
SMA50	-35.24%
SMA200	-49.78%
Trades

Shs Outstand	560.76M
Shs Float	226.91M
Short Float	0.01%
Short Ratio	0.25
Short Interest	0.03M
52W High	14.50 -88.97%
52W Low	1.42 12.68%
Volatility	14.27% 12.36%
ATR (14)	0.23
RSI (14)	35.48
Beta	-
Rel Volume	0.31
Avg Volume	107.92K
Volume	33,796

Perf Week	2.56%
Perf Month	-42.65%
Perf Quarter	-73.29%
Perf Half Y	-
Perf YTD	-60.00%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	-
Target Price	-
Prev Close	1.70
Price	1.60
Change %	-5.88%

Sep-24-26 08:00AM	SL Science Presents Preclinical Data at the 85th Annual Meeting of the Japanese Cancer Association Showing ?d T Cells Target Chemotherapy-Resistant Glioblastoma (GlobeNewswire) -6.02%
Sep-02-26 04:10PM	SL Science Holding Limited Rings Nasdaq Bell, Capping an Active First Quarter as a Publicly Traded Company (GlobeNewswire) +18.64%
Aug-27-26 08:00AM	SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform (GlobeNewswire)
Aug-11-26 08:00AM	SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of ?d T Cell Therapy in Glioblastoma (GlobeNewswire) -5.65%
Jul-17-26 08:00AM	SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology (GlobeNewswire)
08:00AM	Loading…
Jul-10-26 08:00AM	SL Science Holding Limited Submits Orphan Drug Designation Request to the U.S. FDA for GDT Cell Therapy Targeting Glioblastoma (GlobeNewswire)
Jun-18-26 05:13PM	SL Science Holding Limited Reports Full Year 2025 Financial Results (GlobeNewswire) -9.25% -21.93%

SL Science Holding Ltd. operates as a biomedical company. It operates through Exosome products, CD-19 Armed-T products, GDT cell therapy products, corporate and unallocated segments. The firm offers immune cell development, skincare product formulations, cellular and gene therapies. The company was founded by Ching Dong Wang on March 18, 2025 and is headquartered in Taipei, Taiwan.

FounderMr. Ching-Dong Wang

CFO & DirectorMr. Ray Leung

CTO & DirectorDr. Ethan Shen Ph.D.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Wang Ching-Dong	Chief Executive Officer	Sep 29 '26	Buy	2272653.00	4,545,306	10,329,903,316,818	333,832,129	Oct 01 04:30 PM

Open in Screener

XENE

Xenon Pharmaceuticals Inc

38.93

Oct 01 • 3:59 PM ET +1.74 (4.68%)

39.10

Aftermarket • 5:43 PM ET +0.17 (0.44%)

Healthcare Biotechnology Canada Mid NASD

XENE Xenon Pharmaceuticals Inc daily Stock Chart

Peers: ACAD AXSM INCY NBIX BMRN MDGL VKTX ALKS KROS BIIB

| Held by: IWM IWO VTWO IBB TCAF VTWG SPDW FESM SBIO VT

Index	RUT
Market Cap	3.77B
Enterprise Value	2.85B
Income	-409.20M
Sales	0.00M
Book/sh	12.84
Cash/sh	9.61
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	370
IPO	Nov 05, 2014

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	3.03
P/C	4.05
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	21.02
Current Ratio	21.02
Debt/Eq	0.01
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-4.74
EPS next Y	-4.68
EPS next Q	-1.13
EPS this Y	-5.62%
EPS next Y	-1.59%
EPS next 5Y	8.68%
EPS past 3/5Y	-28.36% -40.02%
Sales past 3/5Y	-7.36% -25.26%
EPS Y/Y TTM	-33.88%
Sales Y/Y TTM	-100.00%
EPS Q/Q	-3.62%
Sales Q/Q	-
Earnings	Aug 06 AMC
EPS/Sales Surpr.	2.76% -100.00%

Insider Own	5.21%
Insider Trans	0.51%
Inst Own	100.32%
Inst Trans	1.98%
ROA	-41.54%
ROE	-43.62%
ROIC	-32.80%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-19.25%
SMA50	-31.68%
SMA200	-26.72%
Trades

Shs Outstand	96.75M
Shs Float	91.80M
Short Float	7.02%
Short Ratio	4.59
Short Interest	6.44M
52W High	72.66 -46.42%
52W Low	36.07 7.93%
Volatility	3.78% 4.00%
ATR (14)	2.43
RSI (14)	25.43
Beta	0.60
Rel Volume	2.60
Avg Volume	1.41M
Volume	3,659,146

Perf Week	2.29%
Perf Month	-35.12%
Perf Quarter	-36.14%
Perf Half Y	-31.33%
Perf YTD	-13.14%
Perf Year	-0.49%
Perf 3Y	13.96%
Perf 5Y	149.55%
Perf 10Y	380.62%
Recom	1.16
Target Price	73.53
Prev Close	37.19
Price	38.93
Change %	4.68%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-18-26	Downgrade	Deutsche Bank	Buy → Hold	$46
Feb-24-26	Initiated	Wolfe Research	Outperform	$60
Sep-03-25	Resumed	Wells Fargo	Overweight	$48
May-07-25	Initiated	Chardan Capital Markets	Buy	$55
Feb-11-25	Initiated	Deutsche Bank	Buy	$67
Oct-10-24	Resumed	Raymond James	Outperform	$50
Oct-01-24	Initiated	H.C. Wainwright	Buy	$53
Jan-04-24	Initiated	Citigroup	Buy	$62
Dec-08-23	Initiated	Robert W. Baird	Outperform	$63
Oct-24-23	Resumed	Cantor Fitzgerald	Overweight
Apr-25-23	Initiated	Cantor Fitzgerald	Overweight	$58
Dec-14-22	Initiated	Goldman	Buy	$60
Dec-12-22	Initiated	Cowen	Outperform
Nov-28-22	Initiated	Wells Fargo	Overweight	$50
Oct-19-22	Initiated	Raymond James	Outperform	$52
Aug-29-22	Initiated	BofA Securities	Buy	$45
Jul-21-22	Initiated	JP Morgan	Overweight	$55
Oct-28-21	Initiated	RBC Capital Mkts	Outperform	$43
Oct-02-20	Initiated	SVB Leerink	Outperform	$22
Jul-21-20	Initiated	Needham	Buy	$22

Show Previous Ratings

Today 12:10PM	Xenons Insider Buying Tops $1.6M XENE Stock Heads For Best Day In Over Month (Stocktwits)
Sep-29-26 08:00AM	Ian Mortimer Receives the 2026 Bloom Burton Award (TMX Newsfile)
03:15AM	Defence Therapeutics Appoints Finance Executive Sherry Aulin to Its Board of Directors (TMX Newsfile)
Sep-21-26 04:01PM	Xenon to Present at TD Cowen Novel Mechanisms in Neuropsychiatry & Epilepsy Summit (GlobeNewswire)
07:37AM	Xenon Pharmaceuticals Stock Sinks 31% After Pausing Depression Study Enrollment (TIKR)
04:09PM	Loading…
Sep-18-26 04:09PM	This Biotech Surged 50% On Positive Data In March. Now, It's Completely Gone. (Investor's Business Daily) -30.69%
11:27AM	Xenon Pharmaceuticals falls 30% after depression trial enrollment pause (Proactive)
09:36AM	Netflix downgraded, Etsy upgraded: Wall Street's top analyst calls (The Fly)
08:08AM	Premarket movers: Xenon sinks on trial pause, Netflix hit by downgrade (Investing.com)
07:32AM	Xenon Stock Faces Worst Day Since 2017 as Lead Drug Proves a Double-Edged Sword (Barrons.com)
04:48AM	Premarket movers: Intel, Coinbase, Nucor and Xenon (MarketWatch)
03:37AM	Stock Market Today: Dow set to slip, S&P 500 and Nasdaq head for steady open as oil prices dip but yields tick higher (MarketWatch)
Sep-17-26 04:01PM	Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program (GlobeNewswire)
Sep-10-26 02:14PM	Biohaven Stock Is Sinking. Epilepsy Drug Trial Roadblock Is Only the Latest Blow. (Barrons.com)
Sep-03-26 04:01PM	Xenon to Present at Wells Fargo Healthcare Conference (GlobeNewswire)
04:01PM	Loading…
Aug-28-26 04:01PM	Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-26-26 04:01PM	Xenon to Highlight Phase 3 X-TOLE2 Clinical Data and Rational Polytherapy Potential for Azetukalner at EEC 2026 (GlobeNewswire) +5.58%
Aug-07-26 01:09AM	Xenon Pharmaceuticals Inc (XENE) (Q2 2026) Earnings Call Highlights: Advancing Azetukalner ... (GuruFocus.com)
Aug-06-26 04:32PM	Xenon Pharmaceuticals: Q2 Earnings Snapshot (Associated Press)
04:01PM	Xenon Reports Q2 2026 Financial Results and Provides Business Update (GlobeNewswire)
Jul-31-26 04:01PM	Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-30-26 04:01PM	Xenon to Report Q2 2026 Financial Results on August 6, 2026 (GlobeNewswire)
Jul-02-26 04:01PM	Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-29-26 04:01PM	Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-07-26 04:34PM	Xenon Pharmaceuticals: Q1 Earnings Snapshot (Associated Press)
04:01PM	Xenon Reports Q1 2026 Financial Results and Provides Business Update (GlobeNewswire)
May-01-26 04:01PM	Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
07:30AM	Three Finalists Announced for the 2026 Bloom Burton Award (TMX Newsfile)
Apr-30-26 04:01PM	Xenon to Report Q1 2026 Financial Results on May 7, 2026 (GlobeNewswire)
Apr-19-26 06:00PM	Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting (GlobeNewswire)
08:30AM	Loading…
Apr-15-26 08:30AM	Xenon to Present at Upcoming Investor Conferences (GlobeNewswire)
Apr-07-26 08:30AM	Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting (GlobeNewswire)
Mar-12-26 04:01PM	Xenon Pharmaceuticals Announces Closing of $747.5 Million Upsized Public Offering Including Full Exercise of the Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Mar-11-26 06:00AM	Xenon Pharmaceuticals 10.5M share Spot Secondary priced at $57.00 (TipRanks)
Mar-10-26 10:39PM	Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering (GlobeNewswire)
11:26AM	XENE Stock Up as Azetukalner Meets Goal in Focal Onset Seizures Study (Zacks)
07:00AM	Xenon hits a home run in epilepsy; FDA restarts review of Duchenne cell therapy (BioPharma Dive)
Mar-09-26 07:00PM	50% and 61% Gains in a Single Day: Why XENE and RLMD Soared Today (24/7 Wall St.) +49.64%
04:25PM	Xenon Smashes Its Previous Record High On 'Unprecedented' Results. Is A Buyout Next? (Investor's Business Daily)
04:01PM	Xenon Pharmaceuticals Announces Proposed Public Offering (GlobeNewswire)
01:50PM	Analysts tout market potential of Xenons epilepsy drug on Phase III win (Clinical Trials Arena)
11:47AM	What's Going On With Biohaven Stock On Monday? (Benzinga)
09:26AM	Xenon Pharmaceuticals Rallies After Pivotal Data Shows Major Drop In Monthly Seizures (Benzinga)
07:00AM	Xenon Announces Positive Topline Data from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures (FOS) (GlobeNewswire)
Mar-08-26 02:00PM	Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026 (GlobeNewswire)
Mar-04-26 01:36PM	Xenon Pharmaceuticals Stock Sees RS Rating Rise To 77 (Investor's Business Daily)
Feb-27-26 09:37AM	Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus (Zacks)
Feb-26-26 05:04PM	Xenon Pharmaceuticals: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Xenon Reports Q4 and Full Year 2025 Financial Results and Provides Business Update (GlobeNewswire)
Feb-24-26 01:08PM	Xenon Pharmaceuticals Stock Scores RS Rating Upgrade (Investor's Business Daily)
Jan-20-26 10:42AM	3 Biotech Stocks That Could Double In 2026 (24/7 Wall St.)
Jan-16-26 04:05PM	Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-12-26 08:30AM	Xenon Outlines Key Upcoming Milestones at the 2026 J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-05-26 08:30AM	Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -6.07%
Dec-05-25 09:00AM	Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025 (GlobeNewswire)
Dec-04-25 05:20PM	Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
11:30AM	Mirum Pharmaceuticals (MIRM) Up 1.3% Since Last Earnings Report: Can It Continue? (Zacks)
Dec-03-25 11:30AM	Why Is Xenon Pharmaceuticals (XENE) Up 9.7% Since Last Earnings Report? (Zacks)
08:30AM	Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025 (GlobeNewswire)
Nov-25-25 08:30AM	Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025 (GlobeNewswire)
Nov-06-25 08:30AM	Xenon to Present at Upcoming Investor Conferences (GlobeNewswire)
Nov-04-25 09:54AM	Xenon Q3 Loss Narrower Than Expected, Pipeline Development in Focus (Zacks)
12:01AM	Xenon Pharmaceuticals Inc (XENE) Q3 2025 Earnings Call Highlights: Strong Financial Position ... (GuruFocus.com)
Nov-03-25 04:32PM	Xenon Pharmaceuticals: Q3 Earnings Snapshot (Associated Press Finance)
04:01PM	Xenon Reports Third Quarter 2025 Financial Results & Business Update (GlobeNewswire)
Oct-27-25 08:30AM	Xenon to Report Q3 2025 Financial Results on November 3, 2025 (GlobeNewswire)
Oct-16-25 08:30AM	Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer (GlobeNewswire)
Oct-07-25 04:01PM	Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-25-25 04:01PM	Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain (GlobeNewswire)
Sep-10-25 11:30AM	Why Is Xenon Pharmaceuticals (XENE) Up 4.2% Since Last Earnings Report? (Zacks)
Aug-29-25 04:01PM	Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Aug-12-25 10:16AM	Xenon Q2 Loss Wider Than Expected, Pipeline Development in Focus (Zacks) +5.51%
03:06AM	Xenon Pharmaceuticals Inc (XENE) Q2 2025 Earnings Call Highlights: Strategic Advances and ... (GuruFocus.com)
Aug-11-25 06:03PM	Xenon Pharmaceuticals: Q2 Earnings Snapshot (Associated Press Finance)
04:01PM	Xenon Reports Second Quarter 2025 Financial Results & Business Update (GlobeNewswire)
Aug-04-25 08:01AM	Xenon to Report Q2 2025 Financial Results on August 11, 2025 (GlobeNewswire) +8.72%
Aug-01-25 04:55PM	Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jul-29-25 06:30AM	Compass Pathways Appoints Justin Gover to Board of Directors (Business Wire)
Jul-02-25 03:20AM	RBC Raises Xenon Price Target, Cites Phase III Optimism for Epilepsy Drug (Insider Monkey)
Jun-27-25 04:01PM	Xenon Joins the Russell 3000 and Russell 2000 Indexes (GlobeNewswire)
Jun-26-25 04:01PM	Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-24-25 08:30AM	Xenon Announces Appointment of Darren Cline as Chief Commercial Officer (GlobeNewswire)
Jun-11-25 11:30AM	Xenon Pharmaceuticals (XENE) Up 8.7% Since Last Earnings Report: Can It Continue? (Zacks)
Jun-03-25 04:01PM	Xenon to Present at the Goldman Sachs 46th Annual Global Healthcare Conference (GlobeNewswire)
May-30-25 04:01PM	Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
May-14-25 04:01PM	Xenon to Present at the 2025 RBC Capital Markets Global Healthcare Conference (GlobeNewswire)
08:18AM	Why Xenon Pharmaceuticals Inc. (XENE) Declined on Tuesday (Insider Monkey)
May-13-25 12:07PM	Xenon Q1 Loss Narrower Than Expected, Pipeline Development in Focus (Zacks) -17.43%
03:09AM	Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Call Highlights: Strong Financial Position ... (GuruFocus.com)
May-12-25 04:10PM	Xenon Pharmaceuticals: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Xenon Reports First Quarter 2025 Financial Results and Provides Business Update (GlobeNewswire)
May-09-25 09:24AM	Xenon Pharmaceuticals Inc (XENE) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
May-07-25 08:00AM	Rare Stock Picks In April 2025 - From 16 Discerning Analysts (Seeking Alpha)
May-05-25 04:01PM	Xenon to Report Q1 2025 Financial Results on May 12, 2025 (GlobeNewswire) -6.29%
09:55AM	Wall Street Analysts See a 48.15% Upside in Xenon Pharmaceuticals (XENE): Can the Stock Really Move This High? (Zacks)
May-02-25 04:42PM	Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Apr-18-25 03:36AM	Xenon- A Later Stage Story (Seeking Alpha)
Apr-04-25 04:23PM	Xenon Pharmaceuticals Looks Attractive Before Epilepsy Data (Seeking Alpha)
08:30AM	Xenon to Showcase Long-Term 36-Month Azetukalner Data at AAN 2025 (GlobeNewswire)
Mar-12-25 04:01PM	Xenon to Present at Stifel 2025 Virtual CNS Forum (GlobeNewswire)

Xenon Pharmaceuticals, Inc. is a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need. It develops therapeutics to improve the lives of patients with neurological disorders, including rare central nervous system (CNS) conditions. The company's products include XEN496, XEN1101, XEN901 and XEN007. Xenon Pharmaceuticals was founded by Simon Neil Pimstone, Johannes J. P. Kastelein and Michael R. Hayden on November 5, 1996 and is headquartered in Burnaby, Canada.

CPAMr. Ian C. Mortimer C.M.A.

Chief Financial OfficerMr. Thomas Patrick Kelly J.D.

Chief Legal Officer & Corporate SecretaryMs. Andrea DiFabio J.D.

Chief Medical OfficerDr. Christopher John Kenney M.D.

Chief Commercial OfficerMr. Darren S. Cline M.B.A.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Kelly Thomas Patrick	Chief Financial Officer	Sep 30 '26	Buy	37.32	15,000	559,740	15,000	Oct 01 09:20 AM
MORTIMER IAN	PRESIDENT & CEO	Sep 30 '26	Buy	37.38	30,000	1,121,400	49,923	Oct 01 09:19 AM
Svoronos Dawn	Director	Sep 01 '26	Option Exercise	8.15	5,144	41,924	31,373	Sep 03 08:26 PM
KENNEY CHRISTOPHER JOHN	Chief Medical Officer	Aug 28 '26	Sale	60.25	7,068	425,829	2	Aug 31 09:59 PM
CHRISTOPHER KENNEY	Officer	Aug 28 '26	Proposed Sale	61.93	7,068	437,721		Aug 28 04:25 PM
GANNON STEVEN	Director	Aug 11 '26	Sale	64.06	10,000	640,550	1,870	Aug 13 04:33 PM
STEVEN GANNON	Director	Aug 11 '26	Proposed Sale	64.06	10,000	640,553		Aug 13 04:30 PM
PATOU GARY	Director	Jun 05 '26	Sale	53.14	1,322	70,251	24,896	Jun 08 09:19 PM
Cannon Gillian	Director	Jun 05 '26	Sale	53.14	1,190	63,237	1,455	Jun 08 09:19 PM
GILLIAN CANNON	Director	Jun 05 '26	Proposed Sale	52.99	1,190	63,058		Jun 05 04:32 PM
GARY PATOU	Director	Jun 05 '26	Proposed Sale	52.99	1,322	70,053		Jun 05 04:32 PM
GANNON STEVEN	Director	May 12 '26	Option Exercise	7.38	3,500	25,830	10,641	May 13 09:40 PM
KENNEY CHRISTOPHER JOHN	Chief Medical Officer	Mar 13 '26	Sale	55.23	1,410	77,867	7,069	Mar 13 08:16 PM
DiFabio Andrea	Chief Legal Officer	Mar 13 '26	Sale	55.23	1,342	74,112	7,301	Mar 13 08:16 PM
MORTIMER IAN	PRESIDENT & CEO	Mar 13 '26	Sale	55.23	7,308	403,584	19,923	Mar 13 08:16 PM
CHRISTOPHER JOHN KENNEY	Officer	Mar 13 '26	Proposed Sale	55.22	1,410	77,867		Mar 13 07:51 PM
ANDREA DIFABIO	Officer	Mar 13 '26	Proposed Sale	55.23	1,342	74,112		Mar 13 07:50 PM
IAN MORTIMER	Officer	Mar 13 '26	Proposed Sale	55.22	7,308	403,583		Mar 13 07:49 PM
KENNEY CHRISTOPHER JOHN	Chief Medical Officer	Mar 10 '26	Sale	60.11	2,771	166,559	4,729	Mar 11 07:21 PM
DiFabio Andrea	Chief Legal Officer	Mar 10 '26	Sale	60.11	2,607	156,702	4,893	Mar 11 07:20 PM
MORTIMER IAN	PRESIDENT & CEO	Mar 09 '26	Option Exercise	6.74	270,000	1,819,850	111,000	Mar 11 07:20 PM
MORTIMER IAN	PRESIDENT & CEO	Mar 09 '26	Sale	60.33	270,000	16,289,142	6,000	Mar 11 07:20 PM
MORTIMER IAN	PRESIDENT & CEO	Mar 10 '26	Sale	60.11	11,269	677,357	14,731	Mar 11 07:20 PM
ANDREA DIFABIO	Officer	Mar 10 '26	Proposed Sale	60.11	2,607	156,702		Mar 10 09:01 PM
CHRISTOPHER JOHN KENNEY	Officer	Mar 10 '26	Proposed Sale	60.11	2,771	166,559		Mar 10 08:58 PM
IAN MORTIMER	Officer	Mar 10 '26	Proposed Sale	60.11	11,269	677,357		Mar 10 08:57 PM
IAN MORTIMER	Officer	Mar 09 '26	Proposed Sale	60.33	270,000	16,289,196		Mar 09 04:46 PM
MORTIMER IAN	PRESIDENT & CEO	Jan 02 '26	Option Exercise	7.49	40,000	299,600	46,000	Jan 02 06:49 PM
MORTIMER IAN	PRESIDENT & CEO	Jan 02 '26	Sale	44.43	40,000	1,777,093	6,000	Jan 02 06:49 PM
IAN MORTIMER	Officer	Jan 02 '26	Proposed Sale	44.43	40,000	1,777,166		Jan 02 06:47 PM
MORTIMER IAN	PRESIDENT & CEO	Dec 05 '25	Sale	45.03	14,375	647,306	16,830	Dec 09 07:40 PM
MORTIMER IAN	PRESIDENT & CEO	Dec 08 '25	Sale	45.73	10,830	495,207	6,000	Dec 09 07:40 PM
IAN MORTIMER	Officer	Dec 08 '25	Proposed Sale	45.73	10,830	495,248		Dec 08 05:10 PM
IAN MORTIMER	Officer	Dec 05 '25	Proposed Sale	45.03	14,375	647,360		Dec 05 05:54 PM
MORTIMER IAN	PRESIDENT & CEO	Nov 28 '25	Sale	45.01	97	4,366	31,205	Dec 03 08:20 PM
IAN MORTIMER	Officer	Nov 28 '25	Proposed Sale	45.01	97	4,366		Dec 01 07:36 PM

Open in Screener

CRESY

Cresud ADR

11.36

Oct 01 • 3:59 PM ET -0.15 (-1.30%)

11.36

Aftermarket • 4:15 PM ET 0.00 (0.00%)

Industrials Conglomerates Argentina Small NASD

Peers: AGRO AGCO CNH FMC DE MOS ADM BG CTVA NTR

| Held by: ARGT APIE

Index	-
Market Cap	805.76M
Enterprise Value	2.89B
Income	119.68M
Sales	925.67M
Book/sh	15.47
Cash/sh	7.51
Dividend Est.	0.45 (3.96%)
Dividend TTM	-
Dividend Ex-Date	Nov 28, 2025
Dividend Gr. 3/5Y	- -
Payout	-
Employees	-
IPO	Mar 19, 1997

P/E	6.17
Forward P/E	7.01
PEG	-
P/S	0.87
P/B	0.73
P/C	1.51
P/FCF	-
EV/EBITDA	17.22
EV/Sales	3.13
Quick Ratio	1.13
Current Ratio	1.46
Debt/Eq	1.50
LT Debt/Eq	1.08
Option/Short	Yes / Yes

EPS (ttm)	1.84
EPS next Y	1.62
EPS next Q	-
EPS this Y	-63.61%
EPS next Y	21.68%
EPS next 5Y	-16.39%
EPS past 3/5Y	-21.28% -
Sales past 3/5Y	-2.21% 14.30%
EPS Y/Y TTM	22.29%
Sales Y/Y TTM	11.27%
EPS Q/Q	-36.86%
Sales Q/Q	48.65%
Earnings	-
EPS/Sales Surpr.	- -

Insider Own	0.06%
Insider Trans	-75.70%
Inst Own	19.94%
Inst Trans	-
ROA	2.61%
ROE	13.32%
ROIC	5.86%
Gross Margin	36.97%
Oper. Margin	16.31%
Profit Margin	12.93%
SMA20	-6.90%
SMA50	-1.61%
SMA200	-2.74%
Trades

Shs Outstand	70.93M
Shs Float	70.89M
Short Float	1.31%
Short Ratio	3.23
Short Interest	0.93M
52W High	14.21 -20.06%
52W Low	8.24 37.91%
Volatility	3.62% 4.12%
ATR (14)	0.46
RSI (14)	40.92
Beta	0.69
Rel Volume	1.15
Avg Volume	287.99K
Volume	332,561

Perf Week	-10.83%
Perf Month	-2.66%
Perf Quarter	3.18%
Perf Half Y	-9.63%
Perf YTD	-10.06%
Perf Year	34.14%
Perf 3Y	121.62%
Perf 5Y	232.17%
Perf 10Y	-1.07%
Recom	1.00
Target Price	15.86
Prev Close	11.51
Price	11.36
Change %	-1.30%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-24-08	Upgrade	HSBC Securities	Neutral → Overweight
Jul-19-07	Initiated	HSBC Securities	Neutral
Feb-27-07	Downgrade	UBS	Neutral → Reduce	$22.30

Sep-08-26 09:15AM	CRESUD S.A.C.I.F. y A. announces its results for the Fiscal Year 2026 ended June 30, 2026 (PR Newswire)
Feb-11-26 02:00AM	Cresud SACIF y A (CRESY) Q2 2026 Earnings Call Highlights: Strong Agricultural Yields Amidst ... (GuruFocus.com)
Feb-10-26 09:00AM	CRESUD S.A.C.I.F. y A. announces its results for the second quarter of Fiscal Year 2026 ended December 31, 2025 (PR Newswire)
Nov-13-25 02:01PM	Cresud SACIF y A (CRESY) Q1 2026 Earnings Call Highlights: Strong Crop Yields and Strategic ... (GuruFocus.com)
Sep-06-25 03:01AM	Cresud SACIF y A (CRESY) Q4 2025 Earnings Call Highlights: Strong Net Income and Strategic ... (GuruFocus.com)
05:40PM	Loading…
Sep-04-25 05:40PM	CRESUD S.A.C.I.F. y A. (NASDAQ:CRESY, ByMA:CRES), leading Latin American agricultural company, announces today its results for the Fiscal Year 2025 ended June 30, 2025. (PR Newswire)
May-09-25 09:36AM	CRESUD S.A.C.I.F. y A. announces its results for the third quarter of Fiscal Year 2025 ended March 31, 2025 (PR Newswire)
Feb-10-25 09:13PM	Cresud S.A.C.I.F. y A. announces its results for the second quarter of Fiscal Year 2025 ended December 31, 2024 (PR Newswire) -5.49%
Nov-08-24 09:39AM	CRESUD S.A.C.I.F. y A. announces its results for the first quarter of Fiscal Year 2025 ended September 30, 2024 (PR Newswire)
Sep-05-24 11:27AM	CRESUD S.A.C.I.F. y A. announces its results for Fiscal Year 2024, ended June 30, 2024 (PR Newswire)
May-10-24 09:53PM	CRESY Stock Earnings: Cresud SACIF Reported Results for Q3 2024 (InvestorPlace)
09:27AM	Cresud: Fiscal Q3 Earnings Snapshot (Associated Press Finance)
09:13AM	CRESUD S.A.C.I.F. y A. announces its results for the third quarter of Fiscal Year 2024 ended March 31, 2024 (PR Newswire)
Feb-09-24 11:42AM	Argentina Crop-Science Firm Eyes Agriculture Boom Under Milei (Bloomberg)
Feb-08-24 07:14PM	Cresud: Fiscal Q2 Earnings Snapshot (Associated Press Finance) -5.29%
06:43PM	Loading…
06:43PM	CRESUD S.A.C.I.F. y A. announces its results for the second quarter of Fiscal Year 2024 ended December 31, 2023 (PR Newswire)
Nov-29-23 08:00AM	Argentina elected chainsaw-toting king of the jungle Janvier Milei president these are the companies to watch ahead of the coming economic shock' (Moneywise)
Nov-28-23 12:38PM	Hurry! 3 Argentine Stocks to Buy Before the New President Takes Office (InvestorPlace)
Nov-09-23 08:17AM	Cresud: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
07:56AM	CRESUD S.A.C.I.F. y A. announces its results for the first quarter of Fiscal Year 2024 ended September 30, 2023 (PR Newswire)
Oct-23-23 05:10PM	Argentine Markets Drop Sharply After Ruling Party Presidential Candidate Soars (The Wall Street Journal) -6.54%
Oct-20-23 06:29PM	Cresud S.A.C.I.F. y A. releases material information regarding the dividend approved by the Shareholders' Meeting held on October 5, 2023 (PR Newswire)
Oct-03-23 08:17AM	Ex-Soros Partner Surfs Argentine Crisis With Real Estate Empire (Bloomberg)
Sep-07-23 02:58PM	Cresud: Fiscal Q4 Earnings Snapshot (Associated Press Finance)
01:54PM	CRESUD announces the results for the FY 2023, ended June 30, 2023 (PR Newswire)
Jun-13-23 12:05PM	Top Industrial Stocks for June 2023 (Investopedia)
May-31-23 01:40PM	Can These Small Ag Stocks Get Out From Under Water? (TheStreet.com)
May-16-23 01:02PM	Top Industrial Stocks for May 2023 (Investopedia)
May-11-23 03:03PM	Cresud: Fiscal Q3 Earnings Snapshot (AP Finance)
10:21AM	CRESUD S.A.C.I.F. y A. announces its results for the third quarter of Fiscal Year 2023 ended March 31, 2023 (PR Newswire)
04:11PM	Loading…
Apr-06-23 04:11PM	Top Industrial Stocks for April 2023 (Investopedia)
Feb-15-23 03:36PM	Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria (NASDAQ:CRESY) Q2 2023 Earnings Call Transcript (Insider Monkey)
Feb-10-23 08:01AM	CRESUD SACIFyA announces its results for the second quarter of Fiscal Year 2023 ended December 31, 2022 (PR Newswire)
Nov-11-22 05:47PM	Cresud S.A.C.I.F. y A. announces today its results for the first quarter of FY 2023 ended September 30, 2022 (PR Newswire) +5.13%
Sep-09-22 10:00AM	Edited Transcript of CRES.BA earnings conference call or presentation 9-Sep-22 2:00pm GMT (Thomson Reuters StreetEvents) +7.58%
Sep-07-22 06:56PM	CRESUD S.A.C.I.F y A. announces its results for FY 2022, ended June 30, 2022 (PR Newswire)
Jun-29-22 02:50PM	CRESUD (NASDAQ: CRESY, BYMA: CRES) announces that it has decided to extend the expiration date of the exchange offer for the Series XXIII Notes. (PR Newswire)
Jun-16-22 08:53PM	CRESUD (NASDAQ: CRESY, BYMA: CRES) announces the exchange offer for the Series XXIII Notes (PR Newswire) -5.38%
May-13-22 09:41AM	Cresud S.A.C.I.F. y A. (NASDAQ: CRESY, BYMA: CRES), leading Argentine agricultural company, announces today its results for the third quarter of FY 2022 ended March 31, 2022. (PR Newswire)
Mar-22-22 08:45AM	10 Wheat Stocks to Buy Now (Insider Monkey)
Mar-08-22 02:28PM	Stocks of the Week: Land and Defense Plays (TheStreet.com) -7.88%
Mar-04-22 11:00AM	Let This Value Investor Take You on a Wild Ride to Argentina (TheStreet.com) +18.47%
Feb-14-22 04:30AM	2 Small-Cap Stocks That Are Swimming Nicely Against the Downstream Flow (TheStreet.com)
Feb-11-22 04:22PM	Cresud S.A.C.I.F. y A. (NASDAQ: CRESY, BYMA: CRES), leading Argentine agricultural company, announces today its results for the second quarter of FY 2022 ended December 31, 2021 (PR Newswire)
Jan-27-22 09:38AM	Investmentaktiengesellschaft Fuer Langfristige Inv Buys Carvana Co, StoneCo, MercadoLibre Inc, ... (GuruFocus.com)
Nov-12-21 09:29AM	Cresud S.A.C.I.F. y A. announces today its results for the first quarter of FY 2022 ended September 30, 2021 (PR Newswire)
Jun-18-21 03:03PM	Do Hedge Funds Love Howard Bancorp Inc (HBMD)? (Insider Monkey)
Mar-03-21 05:00AM	Hits and Misses From the Early Days of What Would Become the Pandemic (TheStreet.com)
Feb-25-21 09:16PM	Cresud Sociedad Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria Announces Definitive Subscription Price for Rights Offering (PR Newswire)
Feb-12-21 06:33PM	Cresud Sociedad Anónima Comercial, Inmobiliaria, Financiera y Agropecuaria Announces Submission of Draft Registration Statement for Proposed Rights Offering (PR Newswire) +7.20% +7.08%
Jan-11-21 12:09PM	How To Invest In Farming Without Owning a Farm (Investopedia)
Nov-28-20 09:02PM	Is Cresud Sociedad Anonima Comercial (CRESY) A Good Stock To Buy? (Insider Monkey)
Nov-20-20 07:30PM	Cresud S.A.C.I.F. y A. (CRESY) Q1 2021 Earnings Call Transcript (Motley Fool)
Oct-26-20 12:01PM	CRESUD Exchange Offer Series XXIV (PR Newswire)
Sep-30-20 08:30PM	Cresud S.A.C.I.F. y A. (CRESY) Q4 2020 Earnings Call Transcript (Motley Fool) +5.34%
Sep-29-20 11:14AM	CRESUD S.A.C.I.F y A. announces its Results for the Fiscal Year 2020 ended June 30, 2020 (PR Newswire)
Jun-14-20 09:37PM	Hedge Funds Are Buying Cresud Sociedad Anonima Comercial, Inmobiliaria, Financiera y Agropecuaria (CRESY) (Insider Monkey)
Jun-10-20 08:30PM	Cresud S.A.C.I.F. y A. (CRESY) Q3 2020 Earnings Call Transcript (Motley Fool) -8.65%
Jun-09-20 11:53PM	Cresud S.A.C.I.F. y A. (NASDAQ: CRESY, BYMA: CRES), leading Argentine agricultural company, announces today results for the nine-month period of FY 2020 ended March 31, 2020. (PR Newswire)
Feb-11-20 07:39PM	Cresud S.A.C.I.F. y A announces results for the six-month period of FY 2020 ended December 31, 2019 (PR Newswire)
Jan-07-20 05:30AM	Don't Cry for Me: My Best Stock Pick for 2020 Is From Argentina! (TheStreet.com)
Dec-17-19 04:06PM	Should You Buy Cresud S.A.C.I.F. y A. (CRESY)? (Insider Monkey) +7.84%
Nov-12-19 10:56AM	Do Insiders Own Shares In Crest Resources Inc. (CNSX:CRES)? (Simply Wall St.)
Nov-11-19 10:25PM	Cresud S.A.C.I.F. y A. Announces Results for the three-month period of Fiscal Year 2020 ended September 30, 2019 (PR Newswire)
Nov-09-19 02:57PM	Cresud S.A.C.I.F. y A. (CRESY): Hedge Fund Sentiment Stagnant and Bearish (Insider Monkey)
Nov-08-19 06:30AM	An Argentine Ag Giant Draws This Value Investor Like a Moth to a Flame (TheStreet.com)
Sep-10-19 08:00AM	Cresud SA to Host Earnings Call (ACCESSWIRE)
01:26AM	Cresud S.A.C.I.F. y A. Announces Results for the FY 2019 ended June 30, 2019 (PR Newswire)
Aug-14-19 06:30AM	Argentina's Cresud Suffers at the Hands of a Country in Turmoil (TheStreet.com)
Aug-13-19 03:26PM	Argentina market rout pummels Brazilian hedge fund (Reuters)
Jul-03-19 12:59PM	Argentina Corporates Pay High Price in Return to Debt Market (Bloomberg)
May-13-19 07:46PM	Cresud S.A.C.I.F. y A. Announces Results for the nine-month period of Fiscal Year 2019 ended March 31, 2019 (PR Newswire)
May-09-19 08:47PM	Heres What Hedge Funds Think About Cresud S.A.C.I.F. y A. (CRESY) (Insider Monkey)
Nov-12-18 06:04PM	Cresud: Fiscal 1Q Earnings Snapshot (Associated Press)
05:12PM	Cresud S.A.C.I.F. y A. Announces Results for the first quarter of the Fiscal Year 2019 ended September 30, 2018 (PR Newswire)
Sep-26-18 09:10AM	Report: Exploring Fundamental Drivers Behind Dell Technologies, Kite Realty Group Trust, Fibria Celulose S.A., Cemex S.A.B. de C.V., Suncor Energy, and Cresud S.A.C.I.F. y A. New Horizons, Emerging Trends, and Upcoming Developments (GlobeNewswire)
Sep-06-18 11:29PM	Cresud S.A.C.I.F. y A. Announces Results for the FY 2018 ended June 30, 2018 (PR Newswire)
May-31-18 08:00AM	New Research: Key Drivers of Growth for Cresud S.A.C.I.F. y A, Iamgold, The Habit Restaurants, Hershey, Assured Guaranty, and Apollo Global Management Factors of Influence, Major Initiatives and Sustained Production (GlobeNewswire)
May-14-18 10:33AM	Cresud S.A.C.I.F. y A. Announces Results for the third quarter of FY 2018 ended March 31, 2018 (PR Newswire)
Apr-05-18 07:30AM	Consolidated Research: 2018 Summary Expectations for Bank of Hawaii, Stericycle, Avnet, Hemisphere Media Group, H. B. Fuller, and Cresud S.A.C.I.F. y A Fundamental Analysis, Key Performance Indications (GlobeNewswire)
Mar-09-18 07:55AM	Detailed Research: Economic Perspectives on US Ecology, MDC Partners, British American Tobacco p.l.c, TRI Pointe Group, Cresud S.A.C.I.F. y A, and Ultra Petroleum What Drives Growth in Today's Competitive Landscape (GlobeNewswire)
Feb-14-18 01:45PM	Cresud S.A.C.I.F. y A. Announces Results for the second quarter of FY 2018 ended December 31, 2017 (PR Newswire)
Jan-11-18 03:50PM	6 Stocks Trading Below Peter Lynch Value (GuruFocus.com)
Jan-01-18 11:31AM	ETFs with exposure to Cresud SA : January 1, 2018 (Capital Cube)
Dec-21-17 11:22AM	ETFs with exposure to Cresud SA : December 21, 2017 (Capital Cube)
Dec-20-17 09:20AM	Cresud SA :CRESY-US: Earnings Analysis: Q1, 2018 By the Numbers : December 20, 2017 (Capital Cube)
Nov-14-17 05:01AM	Cresud posts 1Q profit (Associated Press)
Nov-13-17 06:29PM	Cresud S.A.C.I.F. y A. Announces Results for the first quarter of FY 2018 ended September 30, 2017 (PR Newswire)
Nov-10-17 12:06PM	ETFs with exposure to Cresud SA : November 10, 2017 (Capital Cube) -5.04%
Sep-09-17 02:41AM	Cresud S.A.C.I.F. y A. Announces Results for the FY 2017 ended June 30, 2017 (PR Newswire)
Aug-04-17 07:29PM	ETFs with exposure to Cresud SA : August 4, 2017 (Capital Cube)
Jun-23-17 02:15PM	ETFs with exposure to Cresud SA : June 23, 2017 (Capital Cube)
Jun-13-17 12:23PM	ETFs with exposure to Cresud SA : June 13, 2017 (Capital Cube)
Jun-12-17 11:04AM	Cresud SA :CRESY-US: Earnings Analysis: Q3, 2017 By the Numbers : June 12, 2017 (Capital Cube)
May-15-17 06:00AM	Cresud S.A.C.I.F. y A. Announces Results for the Nine-month period of FY 2017 ended March 31, 2017 (PR Newswire)
Apr-05-17 04:34PM	ETFs with exposure to Cresud SA : April 5, 2017 (Capital Cube)
Mar-16-17 04:33PM	Benzinga's Option Alert Recap From March 16
Feb-22-17 10:45AM	Cresud SA :CRESY-US: Earnings Analysis: Q2, 2017 By the Numbers : February 22, 2017 (Capital Cube)
Feb-17-17 10:00AM	2 Farm Names That Could Bear Fruit for the Patient Seed Planter
Feb-13-17 02:36PM	Cresud posts 2Q profit (Associated Press)

Cresud SA engages in the production of basic agricultural commodities. It operates through the Agricultural Business, and Urban Properties and Investment Business segments. The Agricultural Business segment engages in the operation of crop production, cattle feeding, raising, fattening and slaughtering, milk production, sugarcane production, brokerage activities, and sale of supplies. The Urban and Investment Business segment comprises of Operation Center in Argentina, which includes shopping malls, offices, sales and development, hotels, international operations, entertainment activities, and corporate activities, and Operation Center in Israel, which consists of real estate, supermarkets, telecommunications, insurance, other diverse business, and holding companies activities. The company was founded on December 31, 1936 and is headquartered in Buenos Aires, Argentina.

Second Vice ChairmanMr. Alejandro Gustavo Elsztain

Chief Financial & Administrative OfficerMr. Matias Ivan Gaivironsky

Operations ManagerMr. Diego Chillado Biaus

Chief Financial Officer of IsraelMr. Gil Kotler CPA

Chief Executive Officer of IDBD & DICMr. Eran Saar

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Elsztain Alejandro Gustavo	CEO	Sep 30 '26	Buy	11.63	8,573	99,704	1,234,337	Oct 01 03:04 PM
Elsztain Alejandro Gustavo	CEO	Oct 01 '26	Buy	11.37	8,761	99,578	1,243,098	Oct 01 03:04 PM
Elsztain Fernando Adrian	Director	Sep 10 '26	Sale	1.25	65,000	81,250	515,736	Sep 14 10:05 AM
Elsztain Fernando Adrian	Director	Sep 09 '26	Sale	1.19	35,000	41,650	580,736	Sep 14 10:05 AM
Elsztain Fernando Adrian	Director	Aug 24 '26	Sale	1.05	10,000	10,500	615,736	Aug 26 12:39 PM
Elsztain Fernando Adrian	Director	Aug 20 '26	Sale	1.10	10,000	11,000	625,736	Aug 21 12:18 PM
Elsztain Fernando Adrian	Director	Aug 12 '26	Sale	1.06	10,000	10,600	635,736	Aug 13 01:31 PM
Elsztain Fernando Adrian	Director	Jul 22 '26	Sale	1.17	20,000	23,400	645,736	Jul 30 03:15 PM
Elsztain Fernando Adrian	Director	Jul 21 '26	Sale	1.13	15,000	16,950	665,736	Jul 30 03:15 PM
Elsztain Fernando Adrian	Director	Jul 06 '26	Sale	1.11	4,385	4,867	680,736	Jul 30 03:15 PM
Elsztain Fernando Adrian	Director	Jun 11 '26	Sale	1.26	70,000	88,200	685,121	Jul 30 02:29 PM
Elsztain Fernando Adrian	Director	Apr 21 '26	Sale	1.16	31,000	35,960	755,121	Jul 30 02:29 PM
Elsztain Alejandro Gustavo	Director	Jun 05 '26	Buy	10.95	18,200	199,290	1,225,764	Jun 05 04:17 PM
Zang Saul	Director	May 20 '26	Buy	10.63	17,000	180,783	334,720	May 21 03:38 PM
ELSZTAIN EDUARDO S	Director	May 13 '26	Buy	10.57	58,595	619,267	9,845,278	May 15 10:59 AM
ELSZTAIN EDUARDO S	Director	May 14 '26	Buy	10.67	8,823	94,136	9,854,101	May 15 10:59 AM
Elsztain Alejandro Gustavo	Director	Apr 22 '26	Buy	11.23	13,375	150,240	1,203,206	Apr 24 08:10 PM
Elsztain Alejandro Gustavo	Director	Apr 23 '26	Buy	11.20	4,458	49,930	1,207,564	Apr 24 08:10 PM

Open in Screener

UXIN

Uxin Ltd ADR

1.37

Oct 01 • 3:59 PM ET +0.05 (3.79%)

1.35

Aftermarket • 5:09 PM ET -0.02 (-1.48%)

Consumer Cyclical Auto & Truck Dealerships China Small NASD

Peers: ACVA CARG CVNA KMX CARS EBAY AAP AZO GPC ORLY

| Held by: GXC

Index	-
Market Cap	301.18M
Enterprise Value	620.37M
Income	-62.26M
Sales	615.97M
Book/sh	-0.25
Cash/sh	0.06
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	2437
IPO	Jun 27, 2018

P/E	-
Forward P/E	-
PEG	-
P/S	0.49
P/B	-
P/C	24.73
P/FCF	-
EV/EBITDA	-
EV/Sales	1.01
Quick Ratio	0.27
Current Ratio	0.74
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-0.28
EPS next Y	-0.00
EPS next Q	-
EPS this Y	-
EPS next Y	28.56%
EPS next 5Y	-
EPS past 3/5Y	81.48% 59.50%
Sales past 3/5Y	14.47% 35.98%
EPS Y/Y TTM	-42.04%
Sales Y/Y TTM	97.00%
EPS Q/Q	-145.19%
Sales Q/Q	85.83%
Earnings	Sep 24 BMO
EPS/Sales Surpr.	- -

Insider Own	0.05%
Insider Trans	-
Inst Own	1.97%
Inst Trans	16.27%
ROA	-20.01%
ROE	-
ROIC	-42.76%
Gross Margin	4.90%
Oper. Margin	-8.09%
Profit Margin	-10.11%
SMA20	15.66%
SMA50	12.65%
SMA200	-44.37%
Trades

Shs Outstand	219.84M
Shs Float	219.73M
Short Float	0.24%
Short Ratio	1.03
Short Interest	0.52M
52W High	4.18 -67.22%
52W Low	0.90 52.85%
Volatility	13.46% 7.03%
ATR (14)	0.11
RSI (14)	61.30
Beta	0.75
Rel Volume	0.55
Avg Volume	507.02K
Volume	278,629

Perf Week	5.38%
Perf Month	21.24%
Perf Quarter	-15.95%
Perf Half Y	-54.33%
Perf YTD	-59.35%
Perf Year	-59.23%
Perf 3Y	-91.60%
Perf 5Y	-99.51%
Perf 10Y	-
Recom	1.00
Target Price	2.60
Prev Close	1.32
Price	1.37
Change %	3.79%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-23-19	Downgrade	JP Morgan	Overweight → Neutral
Mar-12-19	Initiated	Credit Suisse	Outperform	$7.70
Jan-10-19	Upgrade	JP Morgan	Neutral → Overweight
Dec-21-18	Downgrade	Goldman	Buy → Neutral
Aug-16-18	Initiated	Goldman	Buy

Sep-24-26 03:00PM	Uxin Ltd (UXIN) Q2 2026 Earnings Call Highlights: Surging Retail Volume and Margin Recovery Ahead (GuruFocus.com) +19.27%
09:55AM	Uxin Shares Rise as Q2 Revenue Increases 74.9% and Company Issues Q3 Guidance (InvestorsHub)
04:20AM	Uxin Reports Unaudited Financial Results for the Quarter Ended June 30, 2026 (PR Newswire)
Sep-16-26 06:00AM	Uxin to Report Second Quarter 2026 Financial Results on September 24, 2026 (PR Newswire)
Jul-20-26 04:00AM	Uxin Announces Launch of New Used Car Superstore Project in Shaoxing (PR Newswire) -9.50%
05:00AM	Loading…
Jul-01-26 05:00AM	Uxin Announces Adoption of Rule 10b5-1 Purchase Plan by Entity Controlled by Chairman and CEO (PR Newswire) +25.16%
Jun-29-26 06:00AM	Uxin Announces Closing of US$15 Million Investment from Parties Designated by NIO Capital under Previously Announced Share Subscription Agreements (PR Newswire)
Jun-25-26 07:00AM	Uxin Highlights Operational Strength and Long-Term Growth Strategy at 2026 Investor Day (PR Newswire)
Jun-23-26 06:00AM	Uxin Addresses Investors' Most Frequently Asked Questions on Industry Outlook and Growth Strategy (PR Newswire) -5.26%
Jun-18-26 06:45AM	Uxin Announces Management Share Purchase Plan (PR Newswire) +5.49%
Jun-16-26 03:00PM	Uxin Ltd (UXIN) Q1 2026 Earnings Call Highlights: Surging Retail Sales Amid Market Challenges (GuruFocus.com) -10.38%
03:00AM	Uxin Reports Unaudited Financial Results for the Quarter Ended March 31, 2026 (PR Newswire)
Jun-09-26 06:30AM	Uxin to Report First Quarter 2026 Financial Results on June 16, 2026 (PR Newswire)
Jun-02-26 04:15AM	Uxin Enters into Joint Venture Agreement with Shijiazhuang State-Owned Enterprise (PR Newswire)
May-21-26 03:00AM	Uxin Announces Launch of New Used Car Superstore Project in Chongqing (PR Newswire) -7.56%
03:00AM	Loading…
Apr-11-26 03:00AM	Uxin Ltd (UXIN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Margin Pressures (GuruFocus.com)
Apr-10-26 02:00AM	Uxin Reports Unaudited Financial Results for the Quarter and Full Year Ended December 31, 2025 (PR Newswire)
Apr-06-26 05:00AM	Uxin to Report Fourth Quarter and Full Year 2025 Financial Results on April 10, 2026 (PR Newswire)
Mar-31-26 02:30AM	Uxin Announces Official Opening of Its Tianjin Used Car Superstore (PR Newswire)
Mar-03-26 05:00AM	Uxin Announces Strategic Partnership with State-Owned Enterprises in Jiangyin (PR Newswire)
Dec-26-25 06:00AM	Uxin Announces Entry into Share Subscription Agreements with NIO Capital and Prestige Shine Group Limited (PR Newswire) +6.70%
Dec-18-25 02:00PM	Uxin Ltd (UXIN) Q3 2025 Earnings Call Highlights: Record Growth in Retail Transactions and Revenue (GuruFocus.com) +10.95%
02:00AM	Uxin Reports Unaudited Financial Results for the Quarter Ended September 30, 2025 and Announces Entry into Definitive Agreement for Financing (PR Newswire)
Dec-16-25 09:30PM	Uxin Announces Official Opening of Its Jinan Used Car Superstore (PR Newswire) +6.39%
Dec-12-25 03:00AM	Uxin to Report Third Quarter 2025 Financial Results on December 18, 2025 (PR Newswire)
Nov-12-25 04:30AM	Uxin Announces Strategic Partnership with Tianjin Authorities to Develop Tianjin Used Car Superstore (PR Newswire)
Nov-11-25 06:00AM	Uxin Announces Strategic Partnership with Yinchuan Authorities to Develop Yinchuan Used Car Superstore (PR Newswire)
Oct-31-25 04:40AM	Uxin Announces Strategic Partnership with Guangzhou Authorities to Build Guangzhou Used Car Superstore (PR Newswire)
Sep-29-25 03:00PM	Uxin Ltd (UXIN) Q2 2025 Earnings Call Highlights: Robust Retail Growth Amidst Expansion Challenges (GuruFocus.com)
03:00AM	Uxin Reports Unaudited Financial Results for the Quarter Ended June 30, 2025 (PR Newswire)
02:00AM	Loading…
Sep-26-25 02:00AM	Uxin Announces Grand Opening of Zhengzhou Used Car Superstore (PR Newswire)
Sep-23-25 06:00AM	Uxin to Report Second Quarter 2025 Financial Results on September 29, 2025 (PR Newswire)
Sep-12-25 04:00AM	Uxin to Present at Sidoti September Virtual Investor Conference September 17-18, 2025 (PR Newswire)
Sep-11-25 04:00AM	Uxin to Present at Investor Summit Virtual on September 16, 2025 (PR Newswire) +9.39%
Sep-09-25 01:20PM	John Lin, CFO of Uxin Limited, to Present at Investor Summit Virtual on September 16, 2025 (ACCESSWIRE)
Jul-16-25 07:00AM	Presenting on Emerging Growth Conference 84 Day 2 on July 17; Register to live stream (GlobeNewswire)
Jul-11-25 08:00AM	Uxin to Present at the Emerging Growth Conference on July 17, 2025 (PR Newswire) +33.85%
Jun-13-25 07:45AM	Why Uxin Stock Was Crushing It This Week (Motley Fool) -7.02%
Jun-12-25 04:50AM	Uxin Reports Unaudited Financial Results for the Quarter Ended March 31, 2025 (PR Newswire) -8.49%
Jun-06-25 07:50AM	Uxin to Report First Quarter 2025 Financial Results on June 12, 2025 (PR Newswire)
May-01-25 03:07AM	Uxin Ltd (UXIN) Q4 2024 Earnings Call Highlights: Record Growth and Positive EBITDA Mark a ... (GuruFocus.com) +10.45%
Apr-30-25 11:34PM	Q4 2024 Uxin Ltd Transition Period Ending December 31, 2024 Earnings Call (Thomson Reuters StreetEvents) +9.07%
02:49PM	Uxin Limited (UXIN) Q4 2024 Earnings Call Transcript (Seeking Alpha)
03:32AM	Uxin Full Year 2024 Annual Letter to Shareholders (PR Newswire)
03:30AM	Uxin Reports Unaudited Financial Results for the Quarter and Full Year Ended December 31, 2024 (PR Newswire)
Apr-23-25 05:00AM	Uxin to Report Fourth Quarter and Full Year 2024 Financial Results on April 30, 2025 (PR Newswire)
Mar-26-25 11:22PM	Uxin: Why Its Future Is Still Up In The Air (SeekingAlpha)
Mar-05-25 04:00AM	Uxin Announces Entry into Definitive Agreements for Financing (PR Newswire)
Dec-03-24 08:38AM	Uxin Announces Strategic Partnership with CATL's Subsidiary to Develop Battery Swapping Ecosystem for Used Cars (PR Newswire) +21.09%
Nov-26-24 06:50AM	Uxins Impressive Growth in Q3 2024 Financials (TipRanks) -16.14%
Nov-25-24 03:30AM	Uxin Reports Unaudited Financial Results for the Quarter Ended September 30, 2024 (PR Newswire) -19.49%
03:29AM	Uxin Announces Change of Fiscal Year End (PR Newswire)
Nov-18-24 04:00AM	Uxin to Report Second Quarter Fiscal Year 2025 Financial Results on November 25, 2024 (PR Newswire)
Oct-16-24 07:40AM	Uxin Announces Strategic Partnership with Wuhan City Economic & Technological Development Zone (PR Newswire) +15.12%
Sep-24-24 03:00AM	Uxin Ltd (UXIN) Q1 2025 Earnings Call Transcript Highlights: Strong Retail Sales Growth and ... (GuruFocus.com)
Sep-23-24 10:04PM	Q1 2025 Uxin Ltd Earnings Call (Thomson Reuters StreetEvents) +56.47%
02:26PM	Why Uxin Stock Was Skyrocketing Today (Motley Fool)
04:57AM	Uxin Posts Narrower Loss From Operations In Q1; Revenues Up 38.8% (RTT News)
04:34AM	Uxin Reports Unaudited First Quarter of Fiscal Year 2025 Financial Results (PR Newswire)
Sep-18-24 05:00AM	Uxin to Report First Quarter Fiscal Year 2025 Financial Results on September 23, 2024 (PR Newswire)
Sep-13-24 05:00AM	Uxin Announces Entry into a Memorandum of Understanding for a Proposed Investment (PR Newswire)
Jul-31-24 04:30AM	Uxin Reports Unaudited Fourth Quarter and Fiscal Year 2024 Financial Results (PR Newswire) -6.43%
Jul-25-24 07:00AM	Uxin to Report Fourth Quarter and Fiscal Year 2024 Financial Results on July 31, 2024 (PR Newswire)
Jul-08-24 05:02AM	Uxin Announces Strategic Partnership with Zhengzhou Airport Industry (PR Newswire)
May-01-24 08:52AM	Uxin Limited (NASDAQ:UXIN) Q3 2024 Earnings Call Transcript (Insider Monkey) +5.41%
Apr-25-24 01:54PM	UXIN Stock Earnings: Uxin Reported Results for Q3 2024 (InvestorPlace)
04:33AM	Uxin Reports Unaudited Third Quarter of Fiscal Year 2024 Financial Results (PR Newswire)
Apr-19-24 06:00AM	Uxin to Report Third Quarter Fiscal Year 2024 Financial Results on April 25, 2024 (PR Newswire)
Mar-18-24 05:00AM	Uxin Announces Entry into a Term Sheet for Financing (PR Newswire)
Mar-01-24 06:00AM	Uxin Announces Results of Extraordinary General Meeting (PR Newswire)
Jan-30-24 05:00AM	Uxin to Hold an Extraordinary General Meeting on March 1, 2024 (PR Newswire)
Dec-06-23 03:00AM	Uxin Limited Announces Successful Validation of Superstore Business Model, Significant Reduction in Losses, and Target of Achieving Overall Profitability by 2024 (PR Newswire)
Dec-01-23 08:14AM	Uxin Limited (NASDAQ:UXIN) Q2 2024 Earnings Call Transcript (Insider Monkey) -7.34%
Nov-29-23 12:55AM	Q1 2024 Uxin Ltd Earnings Call (Thomson Reuters StreetEvents) -7.42%
Nov-28-23 03:40AM	Uxin Limited Announces Successful Validation of Superstore Business Model, Significant Reduction in Losses, and Target of Achieving Overall Profitability by 2024 (PR Newswire) -7.30%
03:38AM	Uxin Reports Unaudited Second Quarter of Fiscal Year 2024 Financial Results (PR Newswire)
03:35AM	Uxin Reports Unaudited First Quarter of Fiscal Year 2024 Financial Results (PR Newswire)
Nov-22-23 05:00AM	Uxin to Report First and Second Quarter Fiscal Year 2024 Financial Results on November 28, 2023 (PR Newswire)
Sep-20-23 08:17AM	Uxin Announces RMB1.5 Billion Equity Investment in Its Hefei Subsidiary (PR Newswire)
Aug-17-23 01:10PM	UXIN: Uxin reports strong year over year growth in vehicle units sold. (Zacks)
10:52AM	Uxin Limited (NASDAQ:UXIN) Q4 2023 Earnings Call Transcript (Insider Monkey)
Aug-14-23 10:45PM	Q4 2023 Uxin Ltd Earnings Call (Thomson Reuters StreetEvents) +5.76%
06:00AM	Uxin Reports Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results (PR Newswire)
Aug-08-23 07:00AM	Uxin to Report Fourth Quarter and Fiscal Year 2023 Financial Results on August 14, 2023 (PR Newswire)
May-02-23 09:25AM	UXIN: Update on the companys 3rd fiscal quarter results which were broadly in line with expectations. Strong unit sales growth occurred despite difficult market conditions. (Zacks Small Cap Research)
Apr-17-23 08:07AM	Market Cool On Uxin Limited's (NASDAQ:UXIN) Revenues Pushing Shares 49% Lower (Simply Wall St.) +6.22%
Apr-11-23 10:27PM	Q3 2023 Uxin Ltd Earnings Call (Thomson Reuters StreetEvents) -22.54% -12.70%
04:20AM	Uxin Reports Unaudited Third Quarter of Fiscal Year 2023 Financial Results (GlobeNewswire)
Apr-06-23 07:49AM	Uxin Limited (NASDAQ:UXIN) most popular amongst individual investors who own 34% of the shares, institutions hold 21% (Simply Wall St.)
Apr-05-23 03:30AM	Uxin Provides Updates on Payments Under Financing Transaction and Amended 2019 Note (GlobeNewswire) -6.33%
Mar-30-23 04:30AM	Uxin Reschedules the Release of Its Financial Results for the Third Quarter of Fiscal Year 2023 (GlobeNewswire)
Mar-24-23 06:00AM	Uxin to Report Third Quarter Fiscal Year 2023 Financial Results on March 31, 2023 (GlobeNewswire)
Feb-23-23 04:07PM	12 High Growth Penny Stocks that are Profitable (Insider Monkey)
Jan-10-23 07:47AM	Uxin Limited (NASDAQ:UXIN) Q2 2023 Earnings Call Transcript (Insider Monkey)
Jan-05-23 08:28AM	UXIN: Chinese used car retailer reports 2nd fiscal quarter results which were broadly in line with expectations. Profitable growth is expected to occur in calendar year 2023. (Zacks Small Cap Research) +11.35%
Jan-01-23 07:03AM	Uxin Second Quarter 2023 Earnings: CN¥2.58 loss per share (vs CN¥43.65 loss in 2Q 2022) (Simply Wall St.)
Dec-30-22 06:47AM	Uxin Clocks ~79% Revenue Growth In Q2 (Benzinga) -8.86%
04:48AM	Uxin Reports Unaudited Second Quarter of Fiscal Year 2023 Financial Results (GlobeNewswire)
Dec-23-22 08:00AM	Uxin to Report Second Quarter Fiscal Year 2023 Financial Results on December 30, 2022 (GlobeNewswire)
Dec-22-22 08:00AM	Uxin Completes Major Upgrade on its Xian Inspection and Reconditioning Center (GlobeNewswire)

Uxin Ltd. engages in the operation of an online used car transaction services platform. The company was founded by Dai Kun on August 11, 2011 and is headquartered in Beijing, China.

FounderMr. Kun Dai

PresidentMr. Wenbing A Jing

Chief Financial OfficerMr. Feng Lin

Chief Operating OfficerMr. Zhitian Zhang

Head of Corporate FinanceHenry Tsai

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dai Kun	Chief Executive Officer	Sep 30 '26	Buy	1.34	7,443	9,945	15,883	Oct 01 07:55 AM
Dai Kun	Chief Executive Officer	Sep 29 '26	Buy	1.26	8,440	10,611	8,440	Sep 30 09:31 AM
Li Bin (William)	Director	Sep 23 '26	Buy	0.01	104,931,794	996,852	13,115,578,738	Sep 24 08:29 AM

SLBT

SL Science Holding Ltd

XENE

Xenon Pharmaceuticals Inc

CRESY

Cresud ADR

UXIN

Uxin Ltd ADR

Upgrade your Finviz experience